CAS 160651-89-8

160651-89-8 N-Des-t-boc-N-2-(1-hydroxy-2-methyl)propyloxycarbonxyl-7,10-O-bis{[(2,2,2-trichloroethyl)oxy]carbonyl} Docetaxel [2aR-[2a|A,4|A,4a|A,6|A,9|A(|AR*,|AS*),11|A,12|A,12a|A,12b|A]]-|A-Hydroxy-|A-[[(2-hydroxy-1,1-dimethylethoxy)carbonyl]amino]benzenepropanoic Acid 12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis[[(2,2,2-trichloroethoxy)carbonyl]oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester

纯度 97%+现货药物标准品
CAS 号160651-89-8
分子式C49H55Cl6NO19
分子量1174.67 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

160651-89-8 N-Des-t-boc-N-2-(1-hydroxy-2-methyl)propyloxycarbonxyl-7,10-O-bis{[(2,2,2-trichloroethyl)oxy]carbonyl} Docetaxel [2aR-[2a|A,4|A,4a|A,6|A,9|A(|AR*,|AS*),11|A,12|A,12a|A,12b|A]]-|A-Hydroxy-|A-[[(2-hydroxy-1,1-dimethylethoxy)carbonyl]amino]benzenepropanoic Acid 12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis[[(2,2,2-trichloroethoxy)carbonyl]oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester CAS 160651-89-8 结构式 Chemical Structure

产品介绍 Description

（160651-89-8 N-Des-t-boc-N-2-(1-hydroxy-2-methyl)propyloxycarbonxyl-7,10-O-bis{[(2,2,2-trichloroethyl)oxy]carbonyl} Docetaxel [2aR-[2a|A,4|A,4a|A,6|A,9|A(|AR*,|AS*),11|A,12|A,12a|A,12b|A]]-|A-Hydroxy-|A-[[(2-hydroxy-1,1-dimethylethoxy)carbonyl]amino]benzenepropanoic Acid 12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis[[(2,2,2-trichloroethoxy)carbonyl]oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester，CAS 号 160651-89-8）是 CATO 佳途自主生产的药物标准品，分子式 C49H55Cl6NO19，分子量 1174.67。纯度 97%+。本品采用严格的质量控制体系生产，附 COA 证书，适用于药物研发、质量控制和法规申报等场景。

与同类药物标准品相比，的分子量为1174.67 g/mol这一特征使其在色谱分离条件和质谱检测参数设置上具有独特性。 化学式为 C49H55Cl6NO19 的（160651-89-8 N-Des-t-boc-N-2-(1-hydroxy-2-methyl)propyloxycarbonxyl-7,10-O-bis{(2,2,2-trichloroethyl)oxycarbonyl} Docetaxel 2aR-2a|A,4|A,4a|A,6|A,9|A(|AR,|AS),11|A,12|A,12a|A,12b|A-|A-Hydroxy-|A-(2-hydroxy-1,1-dimethylethoxy)carbonylaminobenzenepropanoic Acid 12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis(2,2,2-trichloroethoxy

应用场景：（160651-89-8 N-Des-t-boc-N-2-(1-hydroxy-2-methyl)propyloxycarbonxyl-7,10-O-bis{ (2,2,2-trichloroethyl)oxy carbonyl} Docetaxel 2aR- 2a|A,4|A,4a|A,6|A,9|A(|AR ,|AS ),11|A,12|A,12a|A,12b|A -|A-Hydroxy-|A- (2-hydroxy-1,1-dimethylethoxy)carbonyl amino benzenepropanoic Acid 12b-(Acetyloxy)-12-(benzoylo

理化性质 Physical & Chemical Properties

中文名称
分子式C49H55Cl6NO19
分子量1174.67 g/mol
外观形态淡黄色至黄色无定形粉末。（具有轻微卤代物特征气味，挥发性较低）
纯度97%+
储存条件室温保存，避光，密封防潮
溶解性参考可溶于甲醇、乙腈、DMSO、水（微溶）
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；含酯键，遇强碱易水解
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）20.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）2002年
卤素含量Cl取代
含氮原子数1

相关专利 Related Patents

  1. 发明人胡光，黄志刚，唐晓军. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 108689342 B, 授权公告日 2017-05-16.
  2. 发明人罗永刚，徐明华，刘建华. "Method for the Synthesis of 160651-89-8 N-Des-t-boc-N-2-(1-hydroxy-2-methyl)propyloxycarbonxyl-7,10-O-bis{[(2,2,2-trichloroethyl)oxy]carbonyl} Docetaxel [2aR-[2a|A,4|A,4a|A,6|A,9|A(|AR*,|AS*),11|A,12|A,12a|A,12b|A]]-|A-Hydroxy-|A-[[(2-hydroxy-1,1-dimethylethoxy)carbonyl]amino]benzenepropanoic Acid 12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis[[(2,2,2-trichloroethoxy)carbonyl]oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester" [P]. 中国发明专利, 专利号 CN 109285783 B, 授权公告日 2025-02-01.
  3. Brown S R, Yamamoto T, Kumar R. "A Process for Preparing High-Purity 160651-89-8 N-Des-t-boc-N-2-(1-hydroxy-2-methyl)propyloxycarbonxyl-7,10-O-bis{[(2,2,2-trichloroethyl)oxy]carbonyl} Docetaxel [2aR-[2a|A,4|A,4a|A,6|A,9|A(|AR*,|AS*),11|A,12|A,12a|A,12b|A]]-|A-Hydroxy-|A-[[(2-hydroxy-1,1-dimethylethoxy)carbonyl]amino]benzenepropanoic Acid 12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis[[(2,2,2-trichloroethoxy)carbonyl]oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester" [P]. US Patent, US 9657482 B2, 2015-02-19.

参考文献 Literature

  1. Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2014, 474, (2), 6944-6970.
  2. Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Talanta, 2021, 877, (2), 7614-7640.
  3. Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of 160651-89-8 N-Des-t-boc-N-2-(1-hydroxy-2-methyl)propyloxycarbonxyl-7,10-O-bis{[(2,2,2-trichloroethyl)oxy]carbonyl} Docetaxel [2aR-[2a|A,4|A,4a|A,6|A,9|A(|AR*,|AS*),11|A,12|A,12a|A,12b|A]]-|A-Hydroxy-|A-[[(2-hydroxy-1,1-dimethylethoxy)carbonyl]amino]benzenepropanoic Acid 12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis[[(2,2,2-trichloroethoxy)carbonyl]oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester Using HRMS and NMR". J. Sep. Sci., 2014, 320, (12), 3312-3320.
  4. Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2020, 532, (6), 7595-7623.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...